Shift from older- to newer-generation antiseizure medications in people with acute ischaemic stroke in Australia: a population-based study.

There has been a shift toward newer-generation ASMs for post-stroke seizures and epilepsy. Concerningly, vulnerable patient groups were more likely to be dispensed older-generation ASMs. This may lead to unnecessary exposure to adverse events and drug-drug interactions. Further research is needed to evaluate comparative effectiveness and safety of newer- and older-generation ASMs in post-stroke populations.